Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 5 - Drugs for disorders of the endocrine system
Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
04/1999
04/15/1999CA2306489A1 Benzothiophenes
04/15/1999CA2304152A1 Novel vitamin d analogues
04/15/1999CA2298527A1 Novel dihydronaphthalene compounds and process for producing the same
04/14/1999EP0907643A1 Compounds with growth hormone releasing properties
04/14/1999EP0907631A1 Inorganic ion receptor-active compounds
04/14/1999EP0862577B1 Sulphamate derivatives of 1,3,5(10)-estratriene derivatives, methods of producing them and pharmaceutical compounds containing them
04/14/1999CN1213964A Antiglucocorticoid drug
04/08/1999WO1999016452A1 THERAPEUTICALLY EFFECTIVE 1α, 25-DIHYDROXYVITAMIN D3 ANALOGS
04/08/1999CA2304056A1 Therapeutically effective 1.alpha., 25-dihydroxyvitamin d3 analogs
04/07/1999EP0906918A2 Process for production of insulin precursors having correctly linked cystein bridges
04/07/1999EP0906421A1 Enhanced efficacy of liposomal antisense delivery
04/07/1999EP0906332A1 7$g(a)-(5-METHYLAMINOPENTYL)-ESTRATRIENES, PROCESS FOR THE PREPARATION THEREOF, PHARMACEUTICAL PREPARATIONS WHICH CONTAIN SAID 7$g(a)-(5-METHYLAMINOPENTYL)-ESTRATRIENES AND USE THEREOF FOR PRODUCTION OF DRUGS
04/07/1999EP0906127A1 Novel devices for transdermal administering of trimegestone
04/07/1999EP0906105A1 Improvement of implantation rates after in vitro fertilization
04/07/1999EP0770059B1 Substituted benzamidines, their production and their use as medicaments
04/06/1999US5891992 Processes for affecting in various ways the metabolism of animals using such modified peptides and vaccines
04/06/1999US5891867 Hormonal medicaments and their use for the correction of oestrogenic deficiencies
04/06/1999US5891844 Compositions for treating IRDS and ARDS with a combination of a Glucocorticosteroid and a lung surfactant, and their use
04/06/1999US5891840 Stabilization of somatotropins by modification of cysteine residues utilizing site directed mutagenesis
04/06/1999CA2074320C Process for the preparation of microspheres made of a biodegradable polymeric material
04/01/1999WO1999015521A1 Benzothiophenes
04/01/1999WO1999015498A1 New npy antagonists
04/01/1999WO1999015181A1 21-hydroxy-6,19-oxidoprogesterone (21oh-6op) and its use as medicament for treating excess of glucocorticoids
04/01/1999WO1999015164A1 Amide derivatives for the treatment of diseases mediated by cytokines
04/01/1999WO1999015016A1 Methods for regulating trka expression
04/01/1999WO1998056812A3 Estrogen receptor crystals and ligands
04/01/1999CA2304138A1 Benzothiophenes
04/01/1999CA2304114A1 Methods for regulating trka expression
04/01/1999CA2303528A1 New npy antagonists
04/01/1999CA2300051A1 Amide derivatives for the treatment of diseases mediated by cytokines
03/1999
03/31/1999EP0905132A1 Benzothiophenes
03/31/1999EP0904099A1 A pharmaceutical formulation containing growth hormone, an amino acid and a non-ionic detergent
03/31/1999EP0904064A1 Oral pharmaceutical compositions containing sex hormones
03/31/1999CN1212255A Biphenylsulfonyl cyanamides, process for their preparation, and their use as medicament
03/30/1999US5889143 Evaluation and treatment of patients with progressive immunosuppression
03/30/1999US5889056 Of nitric oxide synthase; hypotensive agent, antiinflammatory agents, antiarthritic agents
03/30/1999US5888991 Use of phosphorus derivatives of alkaloids for treating endocrinopathies
03/24/1999EP0903339A2 Biphenylsulfonylcyanamides, process for their preparation and their use as medicaments
03/24/1999EP0903146A1 21-Hydroy-6,19-oxidoprogesterone (210h-60p) as antiglucocorticoid
03/24/1999EP0902790A1 Process for preparing steroids having a carboxamide side-chain
03/24/1999CN1211991A Compounds with growth hormone releasing properties
03/24/1999CN1211922A Associations of active principles containing clopidogrel and antithrombotic agent
03/24/1999CN1211921A Benzothiophenes, formulations containing same and process of preparing same
03/23/1999US5885971 Gene therapy by secretory gland expression
03/23/1999US5885592 Methods and pharmaceutical compositions for oral delivery of molecular iodine
03/22/1999CA2247749A1 Biphenylsulfonylcyanamides, process for their preparation, and their use as medicament
03/18/1999WO1999013081A1 EXPRESSION OF GONADOTROPINS IN $i(DICTYOSTELIUM)
03/18/1999WO1999013055A1 Human sigma receptor
03/18/1999WO1999012974A1 Monoclonal antibodies that bind testosterone
03/18/1999WO1999012969A1 Treatment of obesity
03/18/1999WO1999012961A1 Estrogen receptor
03/18/1999WO1999012905A1 Indolecarboxylic compounds and their use as pharmaceutical compounds
03/18/1999WO1999012640A1 Coated particles, methods of making and using
03/18/1999WO1999012567A1 Regulation of osteoclast formation by inhibition of osteoblastic stem cell factor
03/18/1999WO1999012531A2 Hormonal contraceptive
03/18/1999WO1999012529A2 Transdermal therapeutic system comprising a reservoir-type pressure-sensitive adhesive layer and a back layer with uni-directional resilience
03/18/1999WO1999012523A1 Modulation of drug loading in multivesicular liposomes
03/18/1999DE19739916A1 Mittel zur hormonalen Kontrazeption Means for hormonal contraception
03/18/1999CA2569685A1 Indolecarboxylic compounds and their use as pharmaceutical compounds
03/18/1999CA2303479A1 Human sigma receptor
03/18/1999CA2302647A1 Expression of gonadotropins in dictyostelium
03/18/1999CA2301979A1 Regulation of osteoclast formation by inhibition of osteoblastic stem cell factor
03/18/1999CA2300804A1 Monoclonal antibodies that bind testosterone
03/17/1999EP0902025A2 Benzothiophenes for treatment of estrogen related conditions
03/17/1999EP0902022A1 Novel benzofuranone derivatives and process for producing the same
03/17/1999EP0901489A1 Antagonists of gonadotropin releasing hormone
03/17/1999EP0901471A1 Antagonists of gonadotropin releasing hormone
03/17/1999EP0618806B1 A stabilized pharmaceutical formulation comprising growth hormone and asparagine
03/17/1999CN1211254A Fused pyrrolo (2,3-C) carbazole-6-ones which potentiate activity of gamma interferon
03/17/1999CN1211180A Method of treatment with compounds having RAG 'alpha' receptor specific or selective activity
03/16/1999US5883294 Selective thyroid hormone analogs
03/11/1999WO1999011643A1 Heterocyclyl-substituted ring-fused pyridines and pyrimidines as corticotropin releasing hormone (crh) antagonists, useful for treating cns and stress-related disorders
03/11/1999DE19738855A1 Transdermales therapeutisches System mit haftklebender Reservoirschicht und unidirektional elastischer Rückschicht Transdermal therapeutic system with contact adhesive reservoir layer and unidirectional elastic backing
03/11/1999CA2303280A1 Heterocyclyl-substituted ring-fused pyridines and pyrimidines as corticotropin releasing hormone (crh) antagonists, useful for treating cns and stress-related disorders
03/10/1999EP0900799A1 Novel atropisomers of 2,3-disubstituted-(5,6)-heteroarylfused-pyrimidin-4-ones
03/10/1999EP0900234A1 21-substituted progesterone derivatives as new antiprogestational agents
03/10/1999EP0900221A1 Spiroazabicyclic compounds, processes for their preparation, and their pharmaceutical use
03/10/1999CN1210007A Application of tea pigments in preparation of medicine for goiter
03/09/1999US5880135 Antagonist activity with respect to corticotropin releasing hormone
03/09/1999US5880115 Steroid sulfatase inhibitors and methods for making and using the same
03/09/1999US5880113 Antiproliferative agents, cell differentiation inducers
03/09/1999US5879711 Stable antiandrogenic gel composition
03/04/1999WO1999009991A1 Novel amide derivatives
03/04/1999WO1999009987A1 Method for treating premenstrual or late luteal phase syndrome
03/04/1999CA2301566A1 N-acylated lipophilic amino acid derivatives
03/04/1999CA2298979A1 Method for treating premenstrual or late luteal phase syndrome
03/03/1999EP0745080B1 Novel mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace
03/03/1999CN1209841A Biologically active and particularly peptide molecules having potentiating effect on growth hormone biological activity
03/03/1999CN1209811A New 19-nor-pregene derivatives
03/03/1999CN1209802A Synthesis and use of retinene derivative having negative hormone and/or antagonist activities
03/03/1999CN1209744A Vitronectin receptor antagonists
03/03/1999CN1209437A Improved method for obtaining isulin precursor having correctly-bonded cystine bond
03/03/1999CN1042296C Preparation method for medicinal preparation for contraception
02/1999
02/25/1999WO1999009024A1 Phenyl urea and phenyl thiourea derivatives as hfgan72 antagonists
02/25/1999WO1999008682A1 A method of preventing or treating estrogen-dependent diseases and disorders
02/25/1999DE19735711A1 Insulin precursor
02/25/1999CA2300178A1 Phenyl urea and phenyl thiourea derivatives as hfgan72 antagonists
02/24/1999CN1209129A Antagonists of gonadotropin releasing hormone
02/24/1999CN1208623A Application of theaflavine for prepn. of medicine for lowering endotheliotoxin
02/18/1999WO1999007703A1 4-AMINOPYRROLE(3,2-d) PYRIMIDINES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS
1 ... 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 ... 290